Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,181 shares at $293.74 ($2.4M) on 2023-02-21, disclosed to the SEC on 2023-02-22.
Seasonal sale ($2.4M) by EVP, COO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $292.85 | 4,498 | $1.3M | 54.9% |
| 2 | $291.01 | 21 | $6K | 0.3% |
| 3 | $292.77 | 545 | $160K | 6.7% |
| 4 | $292.77 | 545 | $160K | 6.7% |
| 5 | $293.74 | 1,100 | $323K | 13.5% |
| 6 | $294.58 | 736 |
| $217K |
| 9.0% |
| 7 | $294.58 | 736 | $217K | 9.0% |
| Total | $293.27 avg | 8,181 | $2.4M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |